We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$2.07B
AUM Growth
+$304M
Cap. Flow
+$228M
Cap. Flow %
11.06%
Top 10 Hldgs %
26.72%
Holding
186
New
38
Increased
42
Reduced
61
Closed
43

Top Buys

Rank Stock Value
1
HAE icon
Haemonetics
HAE
+$29.1M
2
FUN icon
Cedar Fair
FUN
+$27.5M
3
DV icon
DoubleVerify
DV
+$26.8M
4
CNMD icon
CONMED
CNMD
+$21.8M
5
XRAY icon
Dentsply Sirona
XRAY
+$20.7M

Top Sells

Rank Stock Value
1
AAP icon
Advance Auto Parts
AAP
+$29.3M
2
NGD
New Gold Inc
NGD
+$20.9M
3
WBD icon
Warner Bros
WBD
+$20.7M
4
VRNT
Verint Systems
VRNT
+$19.9M
5
M icon
Macy's
M
+$17.3M

Sector Composition

Rank Sector Weight
1 Technology 20.05%
2 Healthcare 18.45%
3 Consumer Discretionary 15.14%
4 Materials 10.18%
5 Industrials 8.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JACK icon
51
Jack in the Box
JACK
$340M
$14.3M 0.69%
723,147
-146,084
-17% -$2.9M
HELE icon
52
Helen of Troy
HELE
$680M
$14M 0.68%
554,985
+226,263
+69% +$5.48M
GT icon
53
Goodyear
GT
$1.74B
$13.8M 0.67%
+1,838,636
New +$17.3M
GOLD
54
Gold.com Inc
GOLD
$1.26B
$13.4M 0.65%
519,707
-22,432
-4% -$531K
PYPL icon
55
PayPal
PYPL
$50.5B
$13.3M 0.65%
198,761
-158,854
-44% -$11.2M
LZ icon
56
LegalZoom.com
LZ
$973M
$13.3M 0.64%
1,281,765
+390,742
+44% +$3.9M
ACH
57
Accendra Health
ACH
$107M
$13.2M 0.64%
+2,749,122
New +$17.5M
KHC icon
58
Kraft Heinz
KHC
$29.6B
$13M 0.63%
+498,384
New +$13.5M
JAMF
59
DELISTED
Jamf
JAMF
$12.9M 0.62%
1,204,461
+883,077
+275% +$7.99M
RAMP icon
60
LiveRamp
RAMP
$2.3B
$12.7M 0.62%
469,766
+178,799
+61% +$5.28M
NOMD icon
61
Nomad Foods
NOMD
$1.63B
$12.5M 0.61%
952,268
+562,304
+144% +$8.81M
SNAP icon
62
Snap
SNAP
$9.05B
$12.1M 0.59%
1,575,633
-839,030
-35% -$6.96M
M icon
63
Macy's
M
$6.55B
$11.7M 0.57%
652,459
-1,222,766
-65% -$17.3M
RPD icon
64
Rapid7
RPD
$776M
$11.6M 0.56%
616,700
-40,819
-6% -$862K
STT icon
65
State Street
STT
$51.3B
$11.4M 0.55%
98,686
-5,274
-5% -$589K
CAL icon
66
Caleres
CAL
$486M
$11.4M 0.55%
871,600
+143,175
+20% +$2.07M
SBH icon
67
Sally Beauty Holdings
SBH
$1.57B
$11.3M 0.54%
691,036
-994,000
-59% -$12.5M
VSH icon
68
Vishay Intertechnology
VSH
$5.08B
$10.9M 0.53%
710,948
-361,791
-34% -$5.74M
IQV icon
69
IQVIA
IQV
$39.8B
$10.9M 0.53%
57,248
-70,034
-55% -$12.7M
CRM icon
70
Salesforce
CRM
$162B
$10.8M 0.52%
45,727
+26,706
+140% +$6.74M
TDOC icon
71
Teladoc Health
TDOC
$1.29B
$10.6M 0.51%
1,372,977
-73,385
-5% -$573K
MNRO icon
72
Monro
MNRO
$368M
$9.6M 0.46%
534,178
-93,739
-15% -$1.54M
EPC icon
73
Edgewell Personal Care
EPC
$1.29B
$9.07M 0.44%
445,432
+103,095
+30% +$2.42M
FIS icon
74
Fidelity National Information Services
FIS
$21.9B
$8.93M 0.43%
135,426
-10,474
-7% -$764K
TROX icon
75
Tronox
TROX
$993M
$8.86M 0.43%
2,203,876
+922,453
+72% +$4.22M
1 2
3
4 5

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Invenomic Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Invenomic Capital Management held 186 positions worth $2.07B, up 17% from $1.76B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Invenomic Capital Management deployed $228M of net new capital in Q3 2025, opening 38 new positions and adding to 42 existing holdings. Its largest new stake was Cedar Fair: 1,034,288 shares worth $23.5M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Warner Bros, an estimated $20.7M trimmed.

  • Invenomic Capital Management's largest Q3 2025 buy was Cedar Fair: 1,034,288 shares worth $23.5M.
  • Invenomic Capital Management added most to Haemonetics in Q3 2025, an estimated $29.1M increase.
  • Invenomic Capital Management's biggest Q3 2025 reduction was Warner Bros, cutting an estimated $20.7M.
  • Invenomic Capital Management fully exited Advance Auto Parts in Q3 2025, selling an estimated $29.3M.
  • Invenomic Capital Management's ten largest holdings make up 27% of its $2.07B portfolio in Q3 2025.
  • Invenomic Capital Management opened 38 new positions and closed 43 in Q3 2025.
  • Invenomic Capital Management's portfolio value rose 17% quarter-over-quarter to $2.07B.

Based on Invenomic Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.